Clinical TrialsSearch results
Number of results: 568
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Feasibility study of LED-light acupuncture and moxibustion for stiff neck and shoulder
- stiff neck and shoulder
- Odagiri Keiichi
- 2021-01-18
Completed
- Involvement of adenosine receptors with inhalation anesthetics
- Healthy adult
- Sakurai Satoru
- 2020-03-06
Completed
- Nivolumab and Ipilimumab or Nivolumab or Placebo Plus TACE in Intermediate-stage Liver Cancer
- Hepatocellular Carcinoma
- Marina Tschaika
- 2020-10-20
Completed
- P II study of CapeOX therapy for small intestinal cancer
- unresectable or recurrent small bowel adenocarcinoma with no prior treatment
- Yasui Hirofumi
- 2018-11-06
Completed
- Phase II trial evaluating safety and efficacy of ME2136 combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy
- Solid cancer
- Yasui Hirofumi
- 2020-12-10
Completed
- Phase III Study of PEM + CDDP and VNR + CDDP for Completely Resected Non-squamous Non-Small Cell Lung Cancer
- Completely Resected Non-squamous Non-Small Cell Lung Cancer
- Takahashi Toshiaki
- 2018-12-20
Completed
- Post remission therapy including arsenic trioxide against acute promylocytic leukemia (APL) in elderly patients. (JALSG APL212G study)
- Adult acute promylocytic leukemia
- Takeshita Akihiro
- 2019-03-14
Completed
- Post remission therapy with arsenic trioxide and gemtuzumab ozogamicin in acute promylocytic leukemia (JALSG APL212)
- Adult acute promylocytic leukemia
- Takeshita Akihiro
- 2019-03-14
Completed
- Postoperative nausea and vomiting after general anesthesia with Remimazolam.
- General anesthesia
- Suzuki Yuji
- 2021-10-05
Completed
- Predictive effect of remi-mazolam when supraglottic device (i-gel) is inserted.
- Non-emergency patients undergoing surgery under general anesthesia
- Nakajima Yoshiki
- 2021-04-19